Initial public offerings (IPO) are a special type of fund raising. For biotech companies it’s even more special as they are rarely profitable and do not have a commercial track record. How do you present biotech companies aiming for an IPO to investors? What is the role of legal advisors, auditors, and banks in this process? What is needed to conduct a successful IPO?
Even if you are not planning to prepare for an IPO, it is always good to understand the process.
In our workshop we will share real-life experience with you and present speakers, who went through the challenges of a biotech IPO.